Literature DB >> 2399915

Use of the serum creatinine to estimate glomerular filtration rate in health and early diabetic nephropathy. Collaborative Study Group of Angiotensin Converting Enzyme Inhibition in Diabetic Nephropathy.

J Lemann1, A K Bidani, R P Bain, E J Lewis, R D Rohde.   

Abstract

We evaluated 100/serum creatinine, 24-hour creatinine clearance, and simultaneously measured creatinine clearance or creatinine clearance estimated by the formula devised by Cockcroft and Gault in comparison with measurements of glomerular filtration rate (GFR) using iothalamate among 136 patients with diabetic nephropathy. We also evaluated 100/serum creatinine, simultaneously measured creatinine clearance or creatinine clearance estimated by the Cockcroft and Gault formula in comparison with measurements of GFR using inulin among 88 healthy adults, 21 hypercalciuric kidney stone formers and their hypercalciuric relatives, and one man with chronic nephritis. Creatinine clearances measured simultaneously were closely correlated to GFR (r = 0.93) as were creatinine clearances, estimated by the Cockcroft and Gault formula (r = 0.84) when GFR ranged from 16 to 175 mL/min (0.27 to 2.92 mL/s). These observations confirm the clinical use of either creatinine clearances during water diuresis or estimates of creatinine clearance by the Cockcroft and Gault formula in the assessment of kidney function.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2399915     DOI: 10.1016/s0272-6386(12)81023-7

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  6 in total

1.  Cystatin C as a new covariate to predict renal elimination of drugs: application to carboplatin.

Authors:  Fabienne Thomas; Sophie Séronie-Vivien; Laurence Gladieff; Florence Dalenc; Valérie Durrand; Laurence Malard; Thierry Lafont; Muriel Poublanc; Roland Bugat; Etienne Chatelut
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

2.  GFR is better estimated by considering both serum cystatin C and creatinine levels.

Authors:  Yann Bouvet; François Bouissou; Yvon Coulais; Sophie Séronie-Vivien; Mathieu Tafani; Stéphane Decramer; Etienne Chatelut
Journal:  Pediatr Nephrol       Date:  2006-06-22       Impact factor: 3.714

3.  The association of serum lipids and inflammatory biomarkers with renal function in men with type II diabetes mellitus.

Authors:  J Lin; F B Hu; E B Rimm; N Rifai; G C Curhan
Journal:  Kidney Int       Date:  2006-01       Impact factor: 10.612

4.  Monitoring kidney function in diabetic nephropathy.

Authors:  P Rossing; A S Astrup; U M Smidt; H H Parving
Journal:  Diabetologia       Date:  1994-07       Impact factor: 10.122

5.  Kidney transplantation in patients with type 1 diabetes mellitus: long-term prognosis for patients and grafts.

Authors:  H Kim; J S Cheigh
Journal:  Korean J Intern Med       Date:  2001-06       Impact factor: 2.884

6.  The relationship between obesity and diabetic nephropathy in China.

Authors:  Hui-Mei Chen; Wen-Wen Shen; Yong-Chun Ge; Yi-De Zhang; Hong-Lang Xie; Zhi-Hong Liu
Journal:  BMC Nephrol       Date:  2013-03-25       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.